Putin's Quest to Avoid the Grim Reaper: What’s Behind the $26 Billion Longevity Programme?
Why It Matters
The initiative reallocates substantial state resources toward an area with uncertain scientific payoff and limited transparency, raising questions about research credibility and opportunity cost for Russia’s health priorities, while underscoring how authoritarian leaders can nationalize scientific agendas for prestige and political signaling.
Summary
The Wall Street Journal investigation reveals President Vladimir Putin has driven a state-backed “national longevity” initiative that has pledged roughly $26 billion toward anti‑aging research, including bioprinting organs, growing organs in mini‑pigs, peptide therapies and cryotherapy. The program mixes mainstream scientific projects with more speculative claims promoted by Putin’s inner circle and advisers, including his daughter Maria Vorontsova, while some independent Russian scientists say the work lacks peer‑reviewed evidence. Funding decisions appear top‑down and opaque, with former researchers alleging commercial assets were absorbed into state-linked ventures. The effort also functions as a public‑relations project reinforcing Putin’s strongman image.
Comments
Want to join the conversation?
Loading comments...